AMAG Pharma (AMAG) Tops Q2 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Cost of product sales: 25.71M
Today's EPS Names:
ROX, KEEL, SENEA, More
Financial Fact:
Cost of product sales: 25.71M
Today's EPS Names:
ROX, KEEL, SENEA, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of $1.45, $0.25 better than the analyst estimate of $1.20. Revenue for the quarter came in at $127.4 million versus the consensus estimate of $128.52 million.
GUIDANCE:
AMAG Pharma sees FY2016 revenue of $503-553 million, versus the consensus of $533.8 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tecnoglass (TGLS) Tops Q3 EPS by 2c ; Offers Guidance
- Castle Brands (ROX) Tops Q4 EPS by 388c ; Provides EPS range
- Collegium Pharma (COLL) Tops Q3 EPS by 10c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
